Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Barankiewicz

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
The Journal of Pharmacology and Experimental Therapeutics|February 12, 1998
Regulation of adenosine concentration and cytoprotective effects of novel reversible adenosine deaminase inhibitorsJ Barankiewicz, A M Danks, E Abushanab, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 21, 1999
Adenosine kinase inhibitors as a novel approach to anticonvulsant therapyJ B Wiesner, B G Ugarkar, A J Castellino, et al.
Cell Death & Disease|July 27, 2013
GRP78-targeting subtilase cytotoxin sensitizes cancer cells to photodynamic therapyM Firczuk, M Gabrysiak, J Barankiewicz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1995
Inhibition of neutrophil adhesion by adenosine and an adenosine kinase inhibitor. The role of selectinsG S Firestein, D A Bullough, M D Erion, et al.
Molecular and Cellular Biology|February 21, 2008
The von Hippel-Lindau tumor suppressor protein and Egl-9-Type proline hydroxylases regulate the large subunit of RNA polymerase II in response to oxidative stressOlga Mikhaylova, Monika L Ignacak, Teresa J Barankiewicz, et al.
British Journal of Haematology|November 20, 2024
CD71<sup>+</sup> erythroid cells promote multiple myeloma progression and impair anti-bacterial immune responseK Czubak, T M Grzywa, K Sidor-Dzitkowska, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
The Journal of Pharmacology and Experimental Therapeutics|February 12, 1998
Regulation of adenosine concentration and cytoprotective effects of novel reversible adenosine deaminase inhibitorsJ Barankiewicz, A M Danks, E Abushanab, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 21, 1999
Adenosine kinase inhibitors as a novel approach to anticonvulsant therapyJ B Wiesner, B G Ugarkar, A J Castellino, et al.
Cell Death & Disease|July 27, 2013
GRP78-targeting subtilase cytotoxin sensitizes cancer cells to photodynamic therapyM Firczuk, M Gabrysiak, J Barankiewicz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1995
Inhibition of neutrophil adhesion by adenosine and an adenosine kinase inhibitor. The role of selectinsG S Firestein, D A Bullough, M D Erion, et al.
Molecular and Cellular Biology|February 21, 2008
The von Hippel-Lindau tumor suppressor protein and Egl-9-Type proline hydroxylases regulate the large subunit of RNA polymerase II in response to oxidative stressOlga Mikhaylova, Monika L Ignacak, Teresa J Barankiewicz, et al.
British Journal of Haematology|November 20, 2024
CD71<sup>+</sup> erythroid cells promote multiple myeloma progression and impair anti-bacterial immune responseK Czubak, T M Grzywa, K Sidor-Dzitkowska, et al.
Pageof 7